|
Volumn 310, Issue 1, 2013, Pages 31-32
|
Sodium reduction in populations: Insights from the Institute of Medicine Committee
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE;
LIPID;
RENIN;
SODIUM;
ADVERSE OUTCOME;
AFRICAN AMERICAN;
BLOOD PRESSURE MEASUREMENT;
CARDIOVASCULAR RISK;
CEREBROVASCULAR ACCIDENT;
CHRONIC KIDNEY DISEASE;
DIABETES MELLITUS;
DIETARY REFERENCE INTAKE;
HEART EJECTION FRACTION;
HEART FAILURE;
HIGH RISK POPULATION;
HUMAN;
HYPERTENSION;
INSULIN RESISTANCE;
LIFESTYLE MODIFICATION;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
PUBLIC HEALTH SERVICE;
RISK ASSESSMENT;
RISK FACTOR;
SHORT SURVEY;
SODIUM INTAKE;
ARTICLE;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASE;
DRUG EFFECT;
HEALTH CARE POLICY;
MEDICAL RESEARCH;
ORGANIZATION;
PUBLIC HEALTH;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RISK;
STANDARD;
UNITED STATES;
BIOMEDICAL RESEARCH;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASES;
HUMANS;
HYPERTENSION;
INSTITUTE OF MEDICINE (U.S.);
NUTRITION POLICY;
OUTCOME ASSESSMENT (HEALTH CARE);
PUBLIC HEALTH;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK;
SODIUM, DIETARY;
UNITED STATES;
MLCS;
MLOWN;
|
EID: 84879779054
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2013.7687 Document Type: Short Survey |
Times cited : (61)
|
References (10)
|